AKIN GUMP STRAUSS HAUER & FELD

Lobbying for GENENTECH INC · Biopharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · $50,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Health Issues

Issues related to public health preparedness; Issues related to access to drugs for minority communities; Issues related to healthcare education and screening.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.